Evidence map›Paper›PMID 28950850›Full record

ReviewBMC medical research methodology2017

Item response models for the longitudinal analysis of health-related quality of life in cancer clinical trials.

Antoine Barbieri, Jean Peyhardi, Thierry Conroy, Sophie Gourgou, Christian Lavergne, Caroline Mollevi

Abstract readReview
In one paragraph

Review in BMC medical research methodology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Longitudinal analysis of health-related quality of life in cancer clinical trials: methods and interpretation of results.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2021
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Antoine BarbieriBiometrics Unit, Institut du Cancer Montpellier, 208 Avenue des Apothicaires, Montpellier, 34298, France. Antoine.Barbieri@gmail.com.ORCID http://orcid.org/0000-0001-5226-5631
Jean PeyhardiUniversité de Montpellier, Place Eugène Bataillon, Montpellier, 34090, France.
Thierry ConroyFrench National Platform Quality of Life and Cancer, Nancy, France.
Sophie GourgouBiometrics Unit, Institut du Cancer Montpellier, 208 Avenue des Apothicaires, Montpellier, 34298, France.
Christian LavergneInstitut Montpelliérain Alexander Grothendieck, Montpellier, France.
Caroline MolleviBiometrics Unit, Institut du Cancer Montpellier, 208 Avenue des Apothicaires, Montpellier, 34298, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe use of health-related quality of life (HRQoL) as an endpoint in cancer clinical trials is growing rapidly. Hence, research into the statistical approaches used to analyze HRQoL data is of major importance, and could lead to a better understanding of the impact of treatments on the everyday life and care of patients. Amongst the models that are used for the longitudinal analysis of HRQoL, we focused on the mixed models from item response theory, to directly analyze raw data from questionnaires.

methodsWe reviewed the different item response models for ordinal responses, using a recent classification of generalized linear models for categorical data. Based on methodological and practical arguments, we then proposed a conceptual selection of these models for the longitudinal analysis of HRQoL in cancer clinical trials.

resultsTo complete comparison studies already present in the literature, we performed a simulation study based on random part of the mixed models, so to compare the linear mixed model classically used to the selected item response models. As expected, the sensitivity of the item response models to detect random effects with lower variance is better than that of the linear mixed model. We then used a cumulative item response model to perform a longitudinal analysis of HRQoL data from a cancer clinical trial.

conclusionsAdjacent and cumulative item response models seem particularly suitable for HRQoL analysis. In the specific context of cancer clinical trials and the comparison between two groups of HRQoL data over time, the cumulative model seems to be the most suitable, given that it is able to generate a more complete set of results and gives an intuitive illustration of the data.

Indexed as

AlgorithmsHealth StatusLinear ModelsQuality of LifeClinical Trials as TopicHumansLongitudinal StudiesNeoplasmsOutcome Assessment, Health CareSurveys and QuestionnairesHealth-related quality of lifeItem response theoryLongitudinal analysisMixed modelsOrdinal data

Identifiers

PMID28950850
PMCPMC5615461

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.